Anavex Life Sciences
AVXL
AVXL
59 hedge funds and large institutions have $39.7M invested in Anavex Life Sciences in 2019 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
5% more funds holding
Funds holding: 56 → 59 (+3)
83% less call options, than puts
Call options by funds: $233K | Put options by funds: $1.38M
Holders
59
Holding in Top 10
–
Calls
$233K
Puts
$1.38M
Top Buyers
| 1 | +$8.72M | |
| 2 | +$3.97M | |
| 3 | +$1.96M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$751K |
| 5 |
Jane Street
New York
|
+$437K |
Top Sellers
| 1 | -$1.67M | |
| 2 | -$333K | |
| 3 | -$307K | |
| 4 |
Barclays
London,
United Kingdom
|
-$302K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$258K |